logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

ZHONGZHENG INTL (00943) will be temporarily suspended from trading starting on January 2nd.

date
08:47 02/01/2026
avatar
GMT Eight
CICC International (00943) has announced that trading of its shares will be temporarily suspended starting at 9:00 am on January 2, 2026.
ZHONGZHENG INTL (00943) announced that trading of its shares will be temporarily suspended from 9:00 am on January 2, 2026.
Related Articles
HK Stock Market Move | Concept of SaaS Surges, Heavy Acquisition Serves as Agent's Repricing, Institutions Focus on Traditional SaaS Shift to Agent-oriented Paradigm Transition
New stock news: Yifang Biomedical (688382.SH) submits application to the Hong Kong Stock Exchange, focusing on areas such as tumor, autoimmune diseases, and metabolic diseases.
New Stock News | Wan Yi Medical Submits Application to Hong Kong Stock Exchange, Committed to Building a Platform for Physician Academic Development
HK Stock Market Move | Concept of SaaS Surges, Heavy Acquisition Serves as Agent's Repricing, Institutions Focus on Traditional SaaS Shift to Agent-oriented Paradigm Transition
New stock news: Yifang Biomedical (688382.SH) submits application to the Hong Kong Stock Exchange, focusing on areas such as tumor, autoimmune diseases, and metabolic diseases.
New Stock News | Wan Yi Medical Submits Application to Hong Kong Stock Exchange, Committed to Building a Platform for Physician Academic Development
RECOMMEND
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
icon
29/12/2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
icon
29/12/2025
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
icon
29/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.